Takeda Pharmaceutical Company Limited Other Liabilities
Takeda Pharmaceutical Company Limited (TAK) had Other Liabilities of JPY 678.83 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:OtherLiabilities · last filed 2025-06-25
- 2025-03-31: Other Liabilities 678.83B JPY.
- 2024-03-31: Other Liabilities 700.11B JPY.
- 2023-03-31: Other Liabilities 632.08B JPY.
- 2022-03-31: Other Liabilities 652.16B JPY.
| Period end | Other Liabilities | Other Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 678.83B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 700.11B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 632.08B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 652.16B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 599.55B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 552.18B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 512.94B JPY 20-F · filed 2020-06-24 | 513.06B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 332.23B JPY 20-F · filed 2019-06-27 |